Clinical Insights to Complete and Incomplete Surgical Revascularization in Atrial Fibrillation and Multivessel Coronary Disease
暂无分享,去创建一个
S. Mariani | R. Lorusso | P. Suwalski | S. Stefaniak | M. Jemielity | G. Raffa | G. Martucci | W. Wańha | W. Wojakowski | M. Deja | G. Filip | K. Bartus | R. Litwinowicz | M. Zembala | F. Jiritano | M. Kowalewski | D. Jagielak | A. Słomka | Michał Pasierski | J. Rogowski | P. Meani | Matteo Matteucci | Dario Fina | Michalina Kołodziejczak | A. Kowalówka | D. Ronco | Andrzej Łoś | Jakub Staromłyński | J. Finke | Natalia Piekuś-Słomka | Tong Li | Pietro Giorgio Malvidni | M. Kołodziejczak
[1] M. Mack,et al. Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease , 2021, Circulation.
[2] M. Mack,et al. Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study , 2021, Clinical Research in Cardiology.
[3] H. Schunkert,et al. Clinical outcomes of complete versus incomplete revascularization in patients treated with coronary artery bypass grafting: insights from the TiCAB trial. , 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[4] M. Zembala,et al. Multiple Versus Single Arterial Coronary Arterial Bypass Grafting Surgery for Multivessel Disease in Atrial Fibrillation. , 2020, Seminars in thoracic and cardiovascular surgery.
[5] M. Zembala,et al. On-Pump vs Off-Pump coronary artery bypass surgery in atrial fibrillation. Analysis from the polish national registry of cardiac surgery procedures (KROK) , 2020, PloS one.
[6] P. McCarthy,et al. Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation. , 2020, The Journal of thoracic and cardiovascular surgery.
[7] S. Macheers,et al. Priorities in coronary artery bypass grafting: Is midterm survival more dependent on completeness of revascularization or multiple arterial grafts? , 2019, The Journal of thoracic and cardiovascular surgery.
[8] P. McCarthy,et al. Ablation of atrial fibrillation during coronary artery bypass grafting: Late outcomes in a Medicare population. , 2019, The Journal of thoracic and cardiovascular surgery.
[9] M. Zembala,et al. Surgical ablation for atrial fibrillation during isolated coronary artery bypass surgery. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[10] Á. Avezum,et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction. , 2019, The New England journal of medicine.
[11] B. Lindahl,et al. Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome , 2018, Upsala journal of medical sciences.
[12] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[13] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.
[14] G. Religa,et al. Survival after surgical ablation for atrial fibrillation in mitral valve surgery: Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK) , 2019, The Journal of thoracic and cardiovascular surgery.
[15] J. Andreasen,et al. Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting. , 2018, Journal of the American College of Cardiology.
[16] R. Habib,et al. The effect of completeness of revascularization during CABG with single versus multiple arterial grafts , 2018, Journal of cardiac surgery.
[17] G. Lip,et al. P1177Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry , 2018 .
[18] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[19] T. Edvardsen,et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.
[20] R. de Caterina,et al. Complete myocardial revascularization confers a larger clinical benefit when performed with state‐of‐the‐art techniques in high‐risk patients with multivessel coronary artery disease: A meta‐analysis of randomized and observational studies , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[21] L. Køber,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.
[22] H. Suryapranata,et al. Complete revascularisation in ST-elevation myocardial infarction and multivessel disease: meta-analysis of randomised controlled trials , 2015, Heart.
[23] A. Diegeler,et al. Preoperative atrial fibrillation and outcome in patients undergoing on-pump or off-pump coronary bypass surgery: lessons learned from the GOPCABE trial. , 2015, Interactive cardiovascular and thoracic surgery.
[24] J. Légaré,et al. Incomplete revascularization after coronary artery bypass graft operations is independently associated with worse long-term survival. , 2014, The Annals of thoracic surgery.
[25] S. Garcia,et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies. , 2013, Journal of the American College of Cardiology.
[26] Sean M. O'Brien,et al. The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery. , 2013, The Annals of thoracic surgery.
[27] B. Sharma,et al. An Open Label Randomised Controlled Trial of Probiotics for Primary Prophylaxis of Hepatic Encephalopathy in Patients with Cirrhosis , 2013 .
[28] Akshay S. Desai,et al. Strategies for multivessel revascularization in patients with diabetes. , 2012, The New England journal of medicine.
[29] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[30] Antonio Colombo,et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.
[31] Sean M. O'Brien,et al. Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? , 2009, The Journal of thoracic and cardiovascular surgery.
[32] J. Coselli,et al. The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting. , 2009, The Journal of thoracic and cardiovascular surgery.
[33] C. Detter,et al. Preexisting atrial fibrillation as predictor for late-time mortality in patients with end-stage renal disease undergoing cardiac surgery--a multicenter study. , 2008, The Thoracic and cardiovascular surgeon.
[34] R. Yozu,et al. Effects of atrial fibrillation on coronary artery bypass graft flow. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[35] H. Schaff,et al. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). , 2002, Journal of the American College of Cardiology.
[36] P. Rothwell,et al. Meta-analysis of randomised controlled trials , 1997, The Lancet.